Back

Prevalence of subclinical atheromatosis in low-intermediate cardiovascular risk patients with atrial fibrillation

31 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (2) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Maria Luz Fernandez Recalde

Ciudad Autonoma De Buenos Aires (Argentina)

7 More presentations in this session

Presentation thumbnail
Lipid disorder and Inflammation in coronary artery disease: clinical implications on concordance/discordance of RC, LDL and hsCRP
Associate Professor L. Bikdelu (Mashhad, IR)
Abstract Slides Video
Presentation thumbnail
Associations between health literacy, socio-demographics and health behaviours in adults with myocardial infarction: a cross-sectional analysis of the ENHEARTEN Study
Doctor D. Azar (Warragul, AU)
Abstract Slides Video
Presentation thumbnail
Long-term impact of telemedicine for lipid control after an acute coronary syndrome
Mr C. Jimenez Mendez (Cadiz, ES)
Abstract Slides Video
Presentation thumbnail
Impact of intensive low-density lipoprotein cholesterol lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome
Doctor K. Kakehi (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Missed opportunity in primary prevention: an analysis of acute myocardial infarction patients with no history of atherosclerotic cardiovascular disease
Professor N. Danchin (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis
thumbnail
Congress Session
Registries, observational, and other studies on atrial fibrillation
thumbnail
Congress Presentation
Progression of device-detected atrial fibrillation to clinical atrial fibrillation: should we worry?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources